Comparison
2p13 2 Microdeletion Syndrome C4749460 vs 15q11q13 Microduplication Syndrome C2675336
Clinical comparison between 2p13 2 Microdeletion Syndrome and 15q11q13 Microduplication Syndrome for differential diagnosis and treatment planning.
2p13 2 Microdeletion Syndrome C4749460
A rare chromosomal condition where a small segment is missing from chromosome 2. Features vary based on which genes are affected. Care focuses on addressing specific symptoms.
15q11q13 Microduplication Syndrome C2675336
A genetic disorder involving duplication of material from the chromosome 15 region linked to Prader-Willi and Angelman syndromes. Features may include developmental delays, learning difficulties, and sometimes autism spectrum traits. Supportive therapies help manage symptoms.
6 comparison axes
Onset
2p13 2 Microdeletion Syndrome C4749460
0-0
15q11q13 Microduplication Syndrome C2675336
0-3
Onset patterns differ
Severity
2p13 2 Microdeletion Syndrome C4749460
severe
15q11q13 Microduplication Syndrome C2675336
moderate
Different severity levels
Chronic
2p13 2 Microdeletion Syndrome C4749460
Chronic
15q11q13 Microduplication Syndrome C2675336
Chronic
Differing course
Communicable
2p13 2 Microdeletion Syndrome C4749460
No
15q11q13 Microduplication Syndrome C2675336
No
Different transmission
Body System
2p13 2 Microdeletion Syndrome C4749460
congenital
15q11q13 Microduplication Syndrome C2675336
congenital
Same/different system
Category
2p13 2 Microdeletion Syndrome C4749460
rare-disease
15q11q13 Microduplication Syndrome C2675336
genetic
Different category
Bottom line
2p13-2-microdeletion-syndrome-C4749460 and 15q11q13-microduplication-syndrome-C2675336 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2p13 2 Microdeletion Syndrome C4749460 | 15q11q13 Microduplication Syndrome C2675336 | Discriminating power |
|---|---|---|---|
| Genomic change | Small missing segment of chromosome 2 at 2p13.2. | Extra material from chromosome 15q11q13. | High |
| Developmental profile | Features vary by affected genes; no single pattern is established. | Developmental delay, learning difficulty, and sometimes autism traits are described. | Moderate |
| Reported severity | Source severity is severe, but individual findings vary. | Source severity is moderate, with variable support needs. | Low |
When to favor each condition
Choose 2p13 2 Microdeletion Syndrome C4749460 when
A confirmed deletion involves 2p13.2.
The chromosome and deletion direction match the left condition.
High
Phenotype is highly variable without a defined syndrome pattern.
The source emphasizes gene-dependent variability rather than one presentation.
Moderate
Concern begins at birth according to the supplied onset coding.
The left onset code is 0-0, but clinical timing still needs clinician review.
Low
Choose 15q11q13 Microduplication Syndrome C2675336 when
Testing shows duplication of 15q11q13.
This region and duplication direction define the right condition.
High
Developmental delay or learning difficulty is the main concern.
These features are specifically described for the right condition.
Moderate
Autism-spectrum traits occur with the duplication.
Such traits are reported sometimes, but are not required for diagnosis.
Moderate
How key tests differ
| Test | 2p13 2 Microdeletion Syndrome C4749460 | 15q11q13 Microduplication Syndrome C2675336 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May identify a 2p13.2 deletion. | May identify a 15q11q13 duplication. | Copy-number result distinguishes the conditions; clinical correlation is required. |
| Standard karyotype | A microdeletion may be missed. | A microduplication may also be missed. | A normal karyotype does not exclude either condition. |
| Parental genetic studies | May clarify inheritance when a deletion is found. | May clarify inheritance when a duplication is found. | Inheritance and recurrence require genetics counseling; neither result is a diagnosis alone. |
Prognosis comparison
2p13 2 Microdeletion Syndrome C4749460
- Outcome
- Long-term outcome is not established and may be substantial given the severe source label.
- Factors
- Affected genes, confirmed deletion size, and actual symptoms.
15q11q13 Microduplication Syndrome C2675336
- Outcome
- Outcome is variable; source severity is moderate but not individually predictive.
- Factors
- Developmental profile, learning needs, autism traits, and available support.
Time frame: Both are described as chronic; precise milestones are not established.
Clinician interpretation should guide prognosis rather than the label alone.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental support needs | Needs depend on the specific symptoms identified. Supportive therapies may address delay and learning difficulty. No universal complication rate is established. |
| Phenotypic variability | Features vary with the genes involved. Features may range across development, learning, and behavior. An abnormal genetic result is not itself a complete clinical diagnosis. |
| Family implications | Genetic counseling may be appropriate after confirmation. Counseling is also relevant because the region has known syndromic associations. Transmission risk cannot be inferred without family testing. |
Patient education highlights
- HighResult versus diagnosis
A deletion or duplication finding needs clinician and genetics interpretation in the full clinical context.
- HighIndividualized care
Care targets observed symptoms; neither condition has one treatment established here.
- MediumNoncontagious nature
Both are genetic conditions and are not communicable.